Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of PCOS in Overweight Adolescents
NCT00714233Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Aug 2002
- Primary completion
- Apr 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (4 arms), sponsored by University of Rochester. Primary endpoint: Number of Adolescent Girls With PCOS Who Can be Successfully Recruited Into a Randomized Clinical Trial That Includes Lifestyle Modification at 24 weeks. Started Aug 2002; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT00714233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00714233.